Tremblant Capital Group lessened its holdings in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 71.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 91,043 shares of the company's stock after selling 232,480 shares during the quarter. Tremblant Capital Group's holdings in Keurig Dr Pepper were worth $2,323,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in the business. iSAM Funds UK Ltd acquired a new position in Keurig Dr Pepper in the 3rd quarter valued at approximately $3,484,000. NorthRock Partners LLC lifted its holdings in shares of Keurig Dr Pepper by 1.7% during the third quarter. NorthRock Partners LLC now owns 413,254 shares of the company's stock worth $10,542,000 after purchasing an additional 6,973 shares during the period. Harvest Fund Management Co. Ltd lifted its holdings in shares of Keurig Dr Pepper by 8.1% during the third quarter. Harvest Fund Management Co. Ltd now owns 83,372 shares of the company's stock worth $2,124,000 after purchasing an additional 6,259 shares during the period. Slotnik Capital LLC bought a new stake in shares of Keurig Dr Pepper in the third quarter worth $2,551,000. Finally, Private Management Group Inc. acquired a new stake in Keurig Dr Pepper in the third quarter valued at $35,419,000. 93.99% of the stock is currently owned by institutional investors and hedge funds.
Keurig Dr Pepper Price Performance
KDP stock opened at $27.41 on Friday. The company has a quick ratio of 0.43, a current ratio of 0.64 and a debt-to-equity ratio of 0.51. The firm has a market cap of $37.24 billion, a price-to-earnings ratio of 17.92, a PEG ratio of 1.40 and a beta of 0.33. The company's fifty day simple moving average is $28.38 and its 200 day simple moving average is $27.81. Keurig Dr Pepper, Inc has a 12-month low of $25.03 and a 12-month high of $36.12.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its quarterly earnings results on Tuesday, February 24th. The company reported $0.60 earnings per share for the quarter, topping analysts' consensus estimates of $0.59 by $0.01. Keurig Dr Pepper had a return on equity of 11.14% and a net margin of 12.52%.The firm had revenue of $4.50 billion during the quarter, compared to the consensus estimate of $4.35 billion. During the same period last year, the business posted $0.58 EPS. The business's revenue was up 10.6% compared to the same quarter last year. Keurig Dr Pepper has set its FY 2026 guidance at 2.130-2.170 EPS. On average, analysts expect that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 10th. Investors of record on Friday, March 27th will be paid a dividend of $0.23 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a $0.92 annualized dividend and a yield of 3.4%. Keurig Dr Pepper's dividend payout ratio (DPR) is currently 60.13%.
Wall Street Analyst Weigh In
KDP has been the subject of several analyst reports. Jefferies Financial Group lowered Keurig Dr Pepper from a "buy" rating to a "hold" rating and lowered their target price for the stock from $39.00 to $32.00 in a research report on Tuesday, December 16th. Barclays upped their price target on Keurig Dr Pepper from $30.00 to $32.00 and gave the company an "equal weight" rating in a research report on Thursday, February 26th. Piper Sandler increased their price target on Keurig Dr Pepper from $35.00 to $38.00 and gave the company an "overweight" rating in a research note on Monday, December 15th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Keurig Dr Pepper in a research note on Wednesday, January 28th. Finally, UBS Group reiterated a "buy" rating and issued a $36.00 target price on shares of Keurig Dr Pepper in a report on Thursday, February 26th. Ten equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Keurig Dr Pepper presently has a consensus rating of "Moderate Buy" and an average target price of $35.40.
Check Out Our Latest Research Report on Keurig Dr Pepper
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper NASDAQ: KDP is a North American beverage company formed in July 2018 through the combination of Keurig Green Mountain and Dr Pepper Snapple Group. The company designs, manufactures, markets and distributes a wide range of hot and cold beverages and related equipment, combining Keurig's single‑serve coffee systems with a large portfolio of carbonated and noncarbonated drink brands. It operates a network of manufacturing, packaging and distribution facilities to supply retail, foodservice and e-commerce channels across its served markets.
The company's product mix includes single‑serve coffee brewers and coffee pods under the Keurig brand as well as a broad assortment of branded beverages.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.